Shares of PainReform Ltd. (PRFX) are gaining over 11% on Wednesday morning despite no stock-related news to drive the shares. The U.S. stocks opened higher on Wednesday.
PRFX is currently trading at $3.52, up $0.37 or 11.746%, on the Nasdaq, on a volume of 5.1 million shares, up from average volume of 263 thousand. The stock has traded between $2.18 and $7.85 in the 52 week period.
PainReform, a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.